Reducing addiction, promoting competition FDA priorities for 2018
The Food and Drug Administration today announced four priority areas for additional policy activity in 2018: reducing addiction to opioid drugs and cigarettes; promoting innovation and competition; empowering consumers to make informed decisions; and strengthening the FDA workforce. Specific policy efforts include new steps to support and streamline development and approval of treatments that address addiction; reducing burdens for creating and approving generic drugs; and extending new hiring and pay authorities to recruit and retain FDA staff.
Related News Articles
Headline
The Department of Health and Human Services Nov. 12 made two announcements regarding the development of mental health treatments for veterans and other…
Headline
A study on substance-related emergency department visits and hospitalizations published Nov. 4 by The American Journal of Psychiatry found that cannabis was…
Headline
The AHA has released its latest downloadable Fast Facts infographic providing statistics on the number of behavioral health hospitals and hospital services in…
Blog
To reduce suicide in the healthcare workforce, hospitals and health systems must create an environment where workers feel safe asking for help.By Susan…
Headline
HHS awards $383 million in grants for suicide prevention, other behavioral health efforts on 988 Day
The Department of Health and Human Services announced Sept. 8 through the Substance Abuse and Mental Health Services Administration that it will award $383.4…
Headline
The Department of Health and Human Services Aug. 17 announced that it will award $96.7 million in grants through the Substance Abuse and Mental Health Services…